CU6 clarity pharmaceuticals ltd

“ Lantheus the leading radiopharmaceutical-focused company...

  1. 5,509 Posts.
    lightbulb Created with Sketch. 3271
    “ Lantheus the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes”

    Lantheus could be very very interested, & keen - to secure Clarity.

    Very long established radiopharmaceutical company, long history in development and to where the company is positioned today. (since about 1956. )

    Similar market cap to Telix , & Telix is now beating them in the radiopharmaceuticals diagnostic space - Nasdaq Lantheus could likely want to best compete and position for into the future.

    https://www.prnewswire.com/news-releases/lantheus-to-acquire-evergreen-theragnostics-for-upfront-payment-of-250-million-to-drive-strategic-evolution-into-fully-integrated-radiopharmaceutical-leader-302361401.html

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.09
Change
-0.040(1.88%)
Mkt cap ! $671.8M
Open High Low Value Volume
$2.15 $2.21 $2.09 $3.560M 1.666M

Buyers (Bids)

No. Vol. Price($)
3 37360 $2.09
 

Sellers (Offers)

Price($) Vol. No.
$2.10 10220 1
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.